Olaris, founded in 2014 by Liz O’Day, is using “biomarkers of response” to determine the best possible course of drugs to treat patients most effectively.
The company is developing a fully automated genetic analyzer to identify pathogens, bacteria and viruses like the coronavirus, designed to be used at the site of sample collection and return results in about one hour.
New York startup Phosphorus is offering genetic testing for everything from your risk of heart disease to your tolerance for certain drugs to lifestyle changes that will improve your health. The founder believes someday the tests will be standard in pr…
Jack Fernandes is the founder of Regenica Biosciences in San Diego, which he describes as the world’s first medical defense company, predicated on developing advanced measures to counter bio-terrorism.
Blink Health uses the leverage of its more than 600,000 customers to negotiate directly with pharmacies, as opposed to going through the pharmacy benefit managers that currently control the prescription drug business.
Boston startup Brio Systems is aiming the change the way primary care is done in America by using easily administered blood tests to prevent chronic diseases like diabetes.